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Abstract: Arachidonic and docosahexaenoic acids (ARA and DHA) are important during pregnancy.
However, the effects of dietary supplementation on fetal growth and oxidative stress are inconclusive.
We aimed to assess the effect of high ARA and DHA diet during rat gestation on: (1) ARA and DHA
availability in plasma and placenta, (2) fetal growth, and (3) placental oxidative stress, analyzing
the influence of sex. Experimental diet (ED) was prepared by substituting soybean oil in the control
diet (CD) by a fungi/algae-based oil containing ARA and DHA (2:1). Rats were fed with CD or ED
during gestation; plasma, placenta, and fetuses were obtained at gestational day 20. DHA, ARA,
and their precursors were analyzed in maternal plasma and placenta by gas chromatography/mass
spectrophotometry. Fetuses and placentas were weighed, the proportion of fetuses with intrauterine
growth restriction (IUGR) determined, and placental lipid and protein oxidation analyzed. ED fetuses
exhibited lower body weight compared to CD, being >40% IUGR; fetal weight negatively correlated
with maternal plasma ARA, but not DHA. Only ED female placenta exhibited higher lipid and
protein oxidation compared to its CD counterparts; lipid peroxidation is negatively associated with
fetal weight. In conclusion, high ARA during gestation associates with IUGR, through placental
oxidative stress, with females being more susceptible.
Keywords: ARA; DHA; oxidative stress; IUGR; fetus; placenta
Int. J. Mol. Sci. 2018, 19, 3863; doi:10.3390/ijms19123863 www.mdpi.com/journal/ijms
Int. J. Mol. Sci. 2018, 19, 3863 2 of 15
1. Introduction
A maternal diet is critical for a successful pregnancy, as well as for fetal health [1,2]. Fatty acids
(FA) are important biological constituents, with metabolic, structural, and signaling roles, it is well
established that the quantity and quality of dietary fats during pregnancy have relevant effects for
the mother and offspring health [3,4]. Linoleic acid (LA; 18:2n-6) and α-linolenic acid (ALA; 18:3n-3)
are the essential fatty acids from which long-chain polyunsaturated fatty acids (LCPUFAs) can be
synthesized. In the human fetus the most important n-3 and n-6 LCPUFAs are eicosapentaenoic
acid (EPA; 20:5n-3), docosahexaenoic acid (DHA; 22:6n-3), and arachidonic acid (ARA; 20:4n-6) [5].
The fetus has a limited capacity to carry out the synthesis from their precursors LA and ALA, due to
limited enzyme availability, and they are most readily obtained from the maternal dietary intake
and metabolism [6,7]. These FA access the fetus through placental transfer [4], primarily in the last
trimester of pregnancy. Western diets usually exhibit a disequilibrium between n-3 and n-6 FA,
with a larger proportion of the latter [8]. Therefore, it has been proposed that supplementation during
gestation should be based on n-3 FA. However, in humans, the benefits of this supplementation remain
inconclusive, as shown by several systematic reviews [9,10], and more studies are needed to ascertain
the consequences of supplementation with n-3 and n-6 LCPUFAs during pregnancy and their role
for fetal growth [11]. This question also remains controversial in rodents. In mice, there is evidence
that dams supplemented with n-3 LCPUFA tend to produce smaller litters; their pups suckle less and
gain less weight compared to those supplemented with n-6 series [12]. In rats, moderate amounts of
fish oil supplementation during pregnancy do not improve growth, but instead lead to intrauterine
growth restriction (IUGR) [13]. Both ARA and DHA are needed for fetal development, and a deficiency
in one may compromise growth [14]. It has been shown that growth deficiency induced by fish oil
supplementation is related to a reduced ARA availability due to inhibition of its synthesis by the excess
of DHA [15].
Another important aspect of n-3 and n-6 LCPUFAs is their role in oxidative stress and in
inflammatory responses. This is particularly relevant during pregnancy, where oxidative stress has
been implicated in the development of materno-fetal complications such IUGR [16]. LCPUFAs of the
n-3 series exert anti-inflammatory properties, while ARA-derived eicosanoids, such as prostaglandins
and leukotrienes, contribute to inflammation [17]. The role of n-3 PUFAs on oxidative stress also
remains controversial. On one hand, n-3 LCPUFAs are highly susceptible to lipid peroxidation and
there is evidence that supplementation may increase Reactive Oxygen Species (ROS) production and
cellular damage [18]. On the other hand, a ROS scavenger action of n-3, but not n-6 FA, has been
shown in vitro [19] and it has been suggested that supplementation with n-3 LC-PUFAs may limit
oxidative stress [20]. In pregnancy, the effect of n-3 LC-PUFA supplementation on placental oxidative
stress and inflammation seems to be dependent on the dose and timing and further studies are needed
to answer these questions [21].
Our aim was to shed light on some of these aspects. We evaluated the effect of a diet with a high
ARA and DHA content, given during gestation to Sprague Dawley rats, assessing if the supplemented
diet: (1) Increase the availability of ARA and DHA in maternal plasma and placenta; and (2) is
beneficial or detrimental for fetal growth, evaluating the role of placental oxidative stress. We have
also analyzed the possible influence of sex on the responses to the dietary intervention.
2. Results
2.1. Diet Intake
A group of experiments was performed to evaluate the amount of chow the rats consumed during
gestation. We did not detect significant differences in the amount of daily chow between CD-fed and
ED-fed dams (CD = 61.8± 4.1 g/kg/day, n = 6; ED = 59.3± 2.2 g/kg/day, n = 6; p = 0.63; and Student´s
t test). The calculated amount of DHA and ARA ingested by rats fed ED was 164.6 mg/kg/day and
349.5 mg/kg/day, respectively. The LCPUFA were not present in the CD diet.
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2.2. Maternal Plasma Composition
We did not detect statistical differences between CD and ED groups neither in maternal plasma
protein (CD = 82.1± 11.6 mg/mL; ED = 78.9± 7.7 mg/mL; p = 0.74; and Student’s t test) nor in glucose
concentrations (CD = 104.5 ± 16.2 mg/dL; ED = 107.0 ± 8.8 mg/dL; p = 0.96; and Student’s t test).
Plasma ARA, DHA, and their precursors were analyzed in the phospholipid, triglyceride, and free
FA fractions. Since we obtained similar results in all the fractions, we only present the data from
the phospholipid fraction, which is the most representative in plasma. ARA and DHA levels were
significantly higher in ED compared to CD dams (Figure 1A,B). Instead, the concentration of the
precursors LA and ALA were significantly lower in ED compared to CD dams (Figure 1C,D). A negative
correlation was found between ARA and DHA plasma levels (r = −0.94, r2 = 0.88, and p = 0.0001).
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2.3. Gestation Outcome
At the end of gestation ED dams had a significantly lower body weight compared to CD dams
(CD = 447 ± 39 g, n = 13; ED = 401 ± 33 g, n = 9; p = 0.0001; and Student’s t test). However, the weight
of the dam without conceptus was similar in both groups (CD = 369 ± 46 g, n = 12, ED = 355 ± 17 g,
n = 9; p = 0.38; and Student’s t test).
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CD group had an average of 15 ± 3 pups per litter. We observed that the ED group had three
different types of gestation outcome; 4 of the dams had a normal litter size (average 16± 3 pups/litter),
5 dams had small litter size (average 7 ± 4 pups/litter) and IUGR, and 3 of them did not deliver any
pups. In this last case, we evidenced the presence of fetal reabsorption in the uterine horns. None
of the CD dams exhibited small litter size or fetal reabsorption. In ED dams, a relationship between
gestation outcome and LCPUFAs was observed; the highest ARA levels were found in dams with fetal
reabsorption, followed by those with IUGR and the lowest levels were found in dams with normal
fetal growth (Figure 2A). DHA levels followed the opposite pattern (Figure 2B).
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Figure 2. Relationship between fetal outcome and maternal plasma levels of (A) Arachidonic acid
(ARA) and (B) Docosahexaenoic acid (DHA) in experimental diet fed dams. NG, Normal growth;
IUGR, Intrauterine growth restriction; and FR, Fetal reabsorption. Data show mean ± SEM. Between
parenthesis, the sample size is shown. ANOVA. a p < 0.05 FR versus NG; b and p < 0.05 FR versus IUGR.
Average fetal body weight and length were significantly smaller in ED compared with CD fetuses,
both in males and in females (Figure 3A,B). Fetal crown-rump-length (CRL) and body mass index
(BMI) were smaller in ED compared to CD fetuses, both in males and females (Table 1). Considering
IUGR individuals below the 3rd percentile, the percentage of IUGR was larger in ED offspring (40.4%
of males and 50.0% of females) than in the CD group (2.6% of males and 2.9% of females).
Table 1. Fetal anthropometric parameters.
Males Females
CD ED CD ED
CRL (mm) 44.7 ± 0.4 42.7 ± 0.6 a 42.7 ± 0.5 40.4 ± 0.6 a
BMI (g/cm2) 0.254 ± 0.004 0.218 ± 0.004 b 0.258 ± 0.004 0.204 ± 0.004 b
CD, Control diet; ED, Experimental diet; CRL, crown-rump length; BMI, body mass index; a p < 0.05, and b p < 0.001
with respect to sex-matched CD.
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Figure 3. (A) Fetal body weight, (B) fetal body length, (C) placental weight, and (D) fetal
weight/placental weight in control (CD) and experimental diet (ED) fed groups. Data show mean ±
SEM. Between parenthesis, the litter sample size is shown (from each litter 5–6 fetuses of each sex were
averaged). Student’s t test. a p < 0.01 ED versus CD.
2.4. Placenta
Placental weight was significantly larger in ED compared to CD groups in both sexes (Figure 3C).
The relationship fetal body weight/placental weight was significantly smaller in ED rats, both in
males and females (Figure 3D). As observed in plasma, placentas from ED group showed significantly
higher concentrations of ARA and DHA, compared to CD in both males and females (Figure 4A,B).
Regarding the precursors, we found a significantly lower LA in ED group compared to CD in both sexes
(Figure 4C), while there were not significant differences in ALA levels between groups (Figure 4D).
A significant positive correlation was found between maternal plasma and placental ARA levels
(r = 0.94, r2 = 0.87, p = 0.0001), a similar positive correlation was found between maternal plasma and
placental DHA levels (r = 0.79, r2 = 0.62, p = 0.0001).
In the ED group, placentas from IUGR fetuses exhibited a significantly higher ARA and lower
DHA levels compared to those with normal growth; this was observed in both sexes (Figure 5).
A negative correlation was found between placental ARA levels and fetal body weight, both in males
(r = −0.80, r2 = 0.64, p = 0.002) and females (r = −0.84, r2 = 0.72, p = 0.001) (Figure 6A). Instead, there
was a positive correlation between placental DHA levels and fetal weight, both in males (r = 0.72,
r2 = 0.52, p = 0.008) and females (r = 0.66, r2 = 0.43, p = 0.014) (Figure 6B). In the CD group, no significant
correlations were found between LCPUFA and fetal weight. A linear regression model showed that
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female fetuses.Int. J. Mol. Sci. 2018, 19, x 6 of 15 
 
 
Figure 4. Placental levels of (A) Arachidonic acid (ARA), (B) docosahexaenoic acid (DHA), (C) linoleic 
acid (LA), and (D) α-Linolenic acid (ALA) in dams fed with control diet (CD) and experimental diet 
(ED), separated by sex. Data show mean ± SEM. Between parenthesis, the litter sample size is shown 
(from each litter 2–3 placentas of each sex were averaged). Student’s t test. a p < 0.001 ED versus CD. 
 
Figure 5. Relationship between fetal growth and placental levels of (A) arachidonic acid (ARA) and 
(B) docosahexaenoic acid (DHA) in experimental diet, separated by sex. NG, Normal growth; IUGR, 
Intrauterine growth restriction. Data show mean ± SEM. Between parenthesis, the litter sample size 
is shown. ANOVA. a p < 0.001 IUGR versus NG. 
CD ED CD ED
0
5
10
15
20
25
CD ED CD ED
0
2
4
6
CD ED CD ED
0
5
10
15
20
CD ED CD ED
0.00
0.05
0.10
0.15
0.20
(9)
(9)
B) Docosahexaenoic acidA) Arachidonic acid
D) α–Linolenic acidC) Linoleic acid
a
a
a
a
PLACENTA
(9)
(9)
(9)
(9)
(9)
(9)
a
a
Male Female Male Female
Male Female Male Female
AR
A 
(%
 of
 to
tal
 FA
)
DH
A 
(%
 of
 to
tal
 FA
)
LA
 (%
 of
 to
tal
 FA
)
AL
A 
(%
 of
 to
tal
 FA
)
NG IUGR NG IUGR
0
5
10
15
20
25
NG IUGR NG IUGR
0
2
4
6
8
(4)(5)
(4)(5)
B) Docosahexaenoic acidA) Arachidonic acid
a
a
PLACENTA
Male Female Male Female
a
a
AR
A 
(%
 of
 to
tal
 FA
)
DH
A 
(%
 of
 to
tal
 FA
)
Figure 4. Placental levels of (A) Arachidonic acid (ARA), (B) docosahexaenoic acid (DHA), (C) linoleic
acid (LA), and (D) α-Linolenic acid (ALA) in dams fed with control diet (CD) and experimental diet
(ED), separated by sex. Data show mean ± SEM. Between parenthesis, the litter sample size is shown
(from each litter 2–3 placentas of each sex were averaged). Student’s t test. a p < 0.001 ED versus CD.
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Figure 6. Correlations between male and female fetal weights and placental levels of (A) arachidonic
acid and (B) docosahexaenoic acid in experimental diet fed dams. Linear regression model. Significant
interaction is shown as adjusted R2 values.
Both lipid peroxidation and protein oxidation were significantly higher in female placenta from
ED compared to CD group, without significant differences in males (Figure 7). In ED group, a negative
correlation between placental lipid peroxidation and fetal weight was found in females (r = −0.69,
r2 = 0.47, p = 0.05), but not in males (p = −0.15; p = 0.72). No correlation was found between protein
oxidation and fetal weight, either in males (r = −0.13; p = 0.76) or females (r = −0.42; p = 0.26).
A linear regression model showed that placental lipid peroxidation explains 41% of female fetal weight.
In addition, in ED group an association between maternal ARA levels and placenta lipid peroxidation
was found (r = 0.70, r2 = 0.49, p = 0.01). However, this association was not found in the CD group
(r = 0.18, p = 0.76).
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3. Discussion
We aimed to analyze the effects of an experimental rodent diet supplemented with high ARA and
DHA content in order to shed light on the controversy regarding the roles of these semi-essential fatty
acids on fetal growth. We tried to answer the question if ARA supplementation together with DHA
would be beneficial or detrimental, and the relative contribution of each LCPUFA to the response.
The main findings of our study are the harmful effects of an excess in maternal ARA on pregnancy
outcome and fetal growth. Instead, DHA seems to have beneficial effects on fetal growth, even at high
concentrations. We suggest that the deleterious effects of ARA seem to be related to accumulation in
the placenta and increased oxidative damage. Our data also suggests that the LCPUFA in maternal
plasma and in the placenta are not only dependent on dietary intake, but also on individual maternal
metabolism. A summary of the main findings is shown in Figure 8.
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3.1. Maternal Bioavailability of LCPUFA from the Diet
The main difference between CD and ED diet was the type of fat, soybean or Formulaid™,
respectively. The other components were similar in both diets; they were isocaloric and had the same
hardness. The source of DHA in ED was microalgae. We chose this source to avoid possible rejection
of the food by the rats due to fish smell. In fact, we demonstrated that rats ate the same amount of
CD and ED chow during gestation. The analysis of LCPUFA by GC/MS revealed that both ARA and
DHA were absent in CD, but it had the precursors, LA and ALA.
We first aimed to analyze the bioavailability in maternal plasma of dietary LCPUFA. DHA and
ARA from the diet were absorbed, as shown by the higher concentration found in plasma from ED-fed
dams. We provide data only of the phospholipid fraction, which has a lower turnover than plasma
triacylglycerols and better reflects the fatty acid intake [22], but we had similar results in the other
fractions analyzed. The precursors (LA and ALA) were also incorporated from the diet, as shown
by the similar proportion in the diet and in the maternal plasma. LA and ALA were available for
biosynthesis, evidenced by the presence of DHA and ARA in rats fed with CD chow, in which these
FA were absent.
3.2. Effect of Dietary Intervention on Gestation
The experimental diet restricted fetal growth, evidenced by a lower weight and length of the
fetuses at G20. This effect was not related to lack of nutrients, since CD and ED chow had the same
caloric content, similar macronutrient proportion and CD and ED rats ate the same amount of food.
Besides, similar glucose and protein levels were found in the plasma of dams fed with either diet.
The deleterious effect of ED was specific to fetal growth and did not affect maternal weight gain,
evidenced by the similar dam weight without conceptus at the end of gestation (G20).
We also observed different gestational outcomes in response to ED. While some ED-fed rats
had litters of normal weight, length, and number, other dams had offspring with signs of IUGR
and some rats even had complete fetal reabsorption, evidenced in the uterine horns. We found
important to define what we considered IUGR in rats. This is relevant considering the relationship
between fetal growth restriction and disease programming [23]. In this study, we considered growth
restriction a fetal weight below the 3rd percentile, which is a common criterion in humans based only
on weight [24]. Another criterion used in humans to define IUGR is a birth weight below the 10th
percentile if hemodynamic compromise is present [25]. We did not use this standard since we did not
evaluate uterine flow. Our data showed that ED-fed dams had a large proportion of IUGR fetuses
(over 40%). In CD rats less than 2.5% of the animals, fetal growth was restricted. These data were
obtained in fetus from several dams and cannot be attributed to a litter effect, which is important in
studies on the effects of gestational interventions [26]. It would be desirable to confirm if this rate of
IUGR is similar in mice and in other rat strains.
We explored whether the deleterious effects of the experimental diet on fetal growth could be
attributed to ARA or DHA. Our data point out at an excess ARA, as shown by the association between
placental ARA levels and growth restriction. Instead, DHA exhibited a positive relationship with
fetal growth. It is interesting to note that, with the same diet, the dams showed different plasma
concentrations of LCPUFA, which could be attributed to individual differences in the enzymatic
systems implicated in their metabolism. The fact that there was a negative correlation between ARA
and DHA, both in plasma and placenta, suggests that there was an interaction between both LCPUFA.
We suggest that an excess of ARA might be interfering with DHA metabolism since they share some
enzymatic systems. A similar interaction has been previously described in dams exposed to diet
supplemented with fish oil, where excess DHA has been proposed to participate in the reduction of
ARA through decreased expression of ∆6-desaturase [15].
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3.3. Role of Placenta
Our data indicate that the placenta plays a key role in the deleterious response to the diet.
Placental weight was larger in rats exposed to the ED and a close parallelism was found between
DHA and ARA levels in maternal plasma and in the placenta. We suggest that the LCPUFA may be
accumulating in the placenta, being used for placental growth and may not be available for the fetus.
Similar results have been described in other studies using LCPUFA enriched diets, where higher ARA
concentrations decrease fetal growth while they increased placental weight [27]. In ED-fed rats fetal
weight, the placental weight ratio was lower compared to CD rats, suggesting a poorer efficiency of
the placenta to supply sufficient nutrients to meet the fetal growth demand. Similar findings have
been reported in rodent models of IUGR [28]. Furthermore, human pregnancies with IUGR exhibit an
increased n-6 and n-3 FA in the placenta and it has been suggested that, if LCPUFA are preferentially
routed towards placental storage, availability for the fetus may be reduced [29]. Our data show a
lower content of the ARA precursor, LA, in the placenta from ED fed dams. This may suggest that
ARA accumulation may also be due to local synthesis.
Pregnancy is often described as a state of controlled, physiological systemic inflammation
with high levels of ROS, particularly in early stages [30]. However, in excess, oxidative stress and
inflammation lead to adverse pregnancy outcome [31]. We found larger levels of protein and lipid
damage in female placenta from ED-fed dams, suggesting that placenta oxidative stress might be
implicated in the deleterious response to the diet. A positive relationship between maternal ARA
levels and placenta lipid peroxidation was found. However, this relationship was not observed
with DHA. These data indicate an implication of ARA in the oxidative processes, probably through
an inflammatory environment, since ARA-derived eicosanoids contribute to inflammation [17].
Pro-inflammatory cytokines are generated in response to ROS and an increased inflammatory
environment further stimulates ROS generation [32]. Furthermore, there is also evidence that
placental ROS can inhibit fetal growth [4]. Our data let us conclude that high ARA intake may
be accumulated in the placenta, where an excess may compromise fetal growth through an oxidative
stress/inflammation-related mechanism.
3.4. Effect of Sex
Sex differences in response to adverse uterine environment are well recognized. However, the
majority of studies [23], including ours in a rat model of gestational undernutrition, show that in the
short term, females are better adapted to adverse fetal environments [33–35]. In the present study,
both sexes seem to be similarly affected by the diet in terms of growth. However, the contribution of
oxidative stress to IUGR seems to be sex dependent, with a worse adaptation of females. The placenta
plays a key role in the sexual dimorphic response to fetal stressors. On one hand, it is the physical
and metabolic interface between maternal environment and the fetus and it bears the same sex of the
fetus [36]. Besides, IUGR is associated with placental oxidative stress in response to maternal exposure
to adverse factors, such as under nutrition, excess glucocorticoids, or toxic substances [35]. It has been
proposed that murine placental responses to maternal diets exhibit a pronounced sexual dimorphism,
with the female placenta being more sensitive to nutritional interventions with a larger change in gene
expression [37]. Our data also indicate that female placenta has a larger susceptibility to the excess in
dietary ARA, evidenced by the higher oxidative damage to lipids and proteins in response to the ED
and the negative relationship between placental lipid peroxidation and female fetal weight.
In conclusion, the present data demonstrate a relationship between excess ARA in diet during
gestation and fetal growth restriction, while DHA seems to have favorable effects on fetal growth. Our
data points out at the importance of fat content in the diet during pregnancy and the correct use of
LCPUFA supplements in the context of pregnancy. This study has been conducted in rodents and
extrapolation to the human condition should be done with caution.
Int. J. Mol. Sci. 2018, 19, 3863 11 of 15
4. Methods
4.1. Diet Preparation
The experimental diet (ED) was prepared specifically for the study by TestDiet® Company
(Richmond, IN, USA) based on the composition of EuroRodent Diet 22 (Control diet, CD), replacing
the soybean oil by Formulaid™ (2:1) (DSM Nutritional Products, Basel, Switzerland), as energy source.
Formulaid™ (2:1) is an oil derived from fungi and microalgae in the form of triglycerides, containing,
among other fatty acids, ARA (20:4n-6) and DHA (22:6n-3) in the proportion of 2:1. It also contains
ascorbyl palmitate (250 ppm) and tocopherols (250–500 ppm) as antioxidants. During diet preparation,
the oil was protected from exposure to oxygen, it was prepared at low temperature and it was stored
frozen until use.
CD and ED were isoenergetic (4.03 kcal/g) and they did not differ in protein, carbohydrate, total
fat, and vitamin content (Table 2).
Table 2. Composition of the diets.
Diet Composition CD ED
Total digestible nutrients (%) 77.8 73.2
Calories provided by protein (%) 25.9 25.7
Calories provided by CHO (%) 64.8 62.9
Calories provided by fat (%) 9.3 10.7
Protein content (%) 22.0 22.0
CHO (nitrogen free extract) content (%) 55.0 53.9
Total fat content (%) 4.4 4.4
Ash content (%) 5.4 5.4
Fiber maximum content (%) 4.1 4.3
Fat source Soybean oil Formulaid™ 2:1
Composition was provided by manufacturer. Moisture content is assumed to be 10.0% for the purpose of calculations.
CD, control diet; ED, experimental diet; and CHO, carbohydrates.
The fatty acid composition of CD and ED was analyzed by gas chromatography/mass
spectrophotometry (GC/MS), as previously reported by Carnielli [38]. ARA and DHA were not
detectable in CD, while ED had both LC-PUFAs (ARA = 13.5%; DHA = 6.3%; expressed as a percentage
of the total FA composition). The precursors, LA and ALA, were present in both diets (Table 3).
Table 3. Fatty Acid composition of the diets.
Fatty Acids (%) ED CD
Lauric Acid (12:0) 1.3 -
Myristic Acid (14:0) 3.1 0.1
Palmitic Acid (16:0) 14.2 16.3
Palmitoleic Acid (16:1w7) 0.5 0.2
Stearic Acid (18:0) 4.5 2.7
Oleic Acid (18:1w9) 20.8 20.4
Linoleic Acid (18:2w6) 27.5 53.5
Linolenic Acid (18:3w6) 1.0 -
Alpha Linoleic Acid (18:3w3) 3.0 4.6
Arachidic Acid (20:0) 0.4 0.3
Gondoic Acid (20:1w9) 0.2 0.3
Eicosadienoic Acid (20:2w6) 0.2 -
Eicosatrienoic Acid (20:3w6) 0.9 -
Arachidonic Acid (20:4w6) 13.5 -
Eicosapentaenoic Acid (20:5w3) 0.1 -
Behenic Acid (22:0) 0.5 -
Docosahexaenoic Acid (22:6w3) 6.3 -
Lignoceric Acid (24:0) 0.4 -
CD, control diet; ED, experimental diet.
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4.2. Experimental Animals
Experiments were performed in Sprague Dawley rats from the colony maintained at the Animal
House facility of the Universidad Autónoma de Madrid. All experimental procedures were approved
by the Ethics Review Board of Universidad Autónoma de Madrid (Animal Wellbeing Committee,
15 April 2015). These procedures also conformed to the Guidelines for the Care and Use of Laboratory
Animals (NIH publication No. 85-23, revised in 1996), the Spanish legislation (RD 1201/2005) and
the regulations of the local Government (Comunidad Autónoma de Madrid; Experimental Protocol
Number 199/15).
Rats were housed in buckets 36.5/21.5/18.5 cm (length/width/height) on aspen wood bedding
and maintained under controlled conditions (temperature 22 ◦C, relative humidity 40%, and 12/12
light/dark photoperiod) and the welfare of the animals was monitored by staff at least once a day.
4.3. Experimental Procedures
12 weeks old rats were mated and day 1 of gestation was determined in the dams by observation
of sperm in the vaginal smear. Thereafter, they were weighted and randomly allocated to one of the
groups CD (315.6 ± 24.1 g; n = 11) or ED (323.1 ± 12.1 g; n = 12), for the entire gestational period.
In both groups, food and water were provided ad libitum and the diet was changed in the hoppers
every day. A group of experiments was designed to monitor the amount of diet that the dams eat daily.
The experiments were performed at gestational day 20 (G20). The dams were anaesthetized in a
CO2 atmosphere and a blood sample was obtained, in tubes containing heparin, by cardiac puncture.
The blood was centrifuged at 900× g for 10 min at 4 ◦C to obtain plasma which was aliquoted and
stored at −80 ◦C until use. The dam was killed by exsanguination and the uterine horns were carefully
dissected. The individual fetus and placenta pairs were obtained.
The fetuses were sexed; each fetus and its placenta were weighted with a precision scale and the
fetus length was measured with a digital caliper (Conecta, Nessler). Fetal body weight below the 3rd
percentile was established as criteria of IUGR.
Placental tissue was homogenized (100 mg of tissue in 1 mL of NaCl 0.9% solution with protease
inhibitor cocktail) and stored at −80 ◦C for future analysis.
Bradford assay (Bio-Rad) and a digital glucometer (Accu-check Aviva, Roche) were used to assess
maternal plasma protein and glucose concentrations, respectively.
Phospholipids and total FA were assessed in maternal plasma and placentas by GC/MS as
previously reported [38]. Data are expressed as a percentage of the total FA composition.
Oxidative damage to lipids in the placenta was assessed by a lipid Hydroperoxide Assay Kit
(LPO, Bioquochem, Gijón, Spain), which analyses malondialdehyde (MDA) + hydroxynonenal (HNE)
concentrations. The experiments were performed according to the manufacturer’s instructions and the
data were expressed as µmol.
Oxidative damage to proteins was assessed by 2,4 dinitrophenylhydrazine-based assay that
detects protein carbonyls [39], adapted to microplate reader [40], using extinction coefficient of
2,4-dinitrophenylhydrazine (ε 22,000 M/cm). The absorbance was measured at 595 nm in a Synergy
HT Multi-Mode Microplate Reader (SynergyTM-HT, BioTek, Winooski, VT, USA) and the data were
expressed as nmol/mg protein.
4.4. Statistical Analysis
All the variables analyzed followed a normal distribution (Kolmogorov-Smirnov test). Data are
expressed as mean ± SEM, considering the litter as sample number. From each dam data of males and
females were averaged. Data were analyzed by Student’s t test or ANOVA, using a linear regression
model, with maternal diet and fetal sex (where applicable) as co-variables. Correlations were evaluated
by Pearson’s p (p). The probability value (p) at which differences were considered significant was
p < 0.05. Statistical analysis was performed with SPSS 22.0 (IBM, Corp., Armonk, NY, USA).
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